Virus Infection, RNA Recruiting Phase 3 Trials for Bevacizumab (DB00112)

Also known as: RNA Virus Infections

IndicationStatusPhase
DBCOND0138959 (Virus Infection, RNA)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04822818EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19Treatment